{"count":25,"summary":"Found 25 ATM offerings in the past 72 hours. Top filers: HeartBeam, Inc., Replimune Group, Inc., RIVERNORTH OPPORTUNITIES FUND, INC..","filings":[{"accession_number":"0001213900-26-090239","company_name":"HeartBeam, Inc.","filed_at":"2026-08-14T17:01:04-04:00","cik":"1779372","form_type":"424B5","shelf_size_usd":100000000,"shelf_size_million_usd":100.0,"is_atm":true,"sales_agents":[],"use_of_proceeds_excerpt":"S-8 MARKET PRICE OF OUR COMMON STOCK S-8 DIVIDEND POLICY S-8 DESCRIPTION OF SECURITIES WE ARE OFFERING S-9 PLAN OF DISTRIBUTION S-10 LEGAL MATTERS S-11 EXPERTS S-11 INCORPORATION BY REFERENCE S-12 Prospectus ABOUT THIS PROSPECTUS ii THE COMPANY 1 RIS"},{"accession_number":"0001104659-26-097309","company_name":"Replimune Group, Inc.","filed_at":"2026-08-14T16:52:10-04:00","cik":"1737953","form_type":"S-3ASR","shelf_size_usd":null,"shelf_size_million_usd":null,"is_atm":true,"sales_agents":[],"use_of_proceeds_excerpt":"​ ​ ​ ​ 6 ​ ​ DESCRIPTION OF CAPITAL STOCK ​ ​ ​ ​ 7 ​ ​ DESCRIPTION OF DEBT SECURITIES ​ ​ ​ ​ 12 ​ ​ DESCRIPTION OF WARRANTS ​ ​ ​ ​ 18 ​ ​ DESCRIPTION OF UNITS ​ ​ ​ ​ 20 ​ ​ FORMS OF SECURITIES ​ ​ ​ ​ 20 ​ ​ PLAN OF DISTRIBUTION ​ ​ ​ ​ 22 ​ ​ L"},{"accession_number":"0001398344-26-014664","company_name":"RIVERNORTH OPPORTUNITIES FUND, INC.","filed_at":"2026-08-14T16:26:24-04:00","cik":"1501072","form_type":"424B5","shelf_size_usd":5040000000,"shelf_size_million_usd":5040.0,"is_atm":true,"sales_agents":[],"use_of_proceeds_excerpt":"S-9 Plan Of Distribution S-9 Legal Matters S-10 Incorporation by Reference S-11 Additional Information S-12 Prospectus Prospectus Summary 6 Summary Of Fund Expenses 26 Financial Highlights 28 Information Regarding Senior Securities 32 The Fund 33 Mar"},{"accession_number":"0001213900-26-090125","company_name":"60 DEGREES PHARMACEUTICALS, INC.","filed_at":"2026-08-14T16:24:56-04:00","cik":"1946563","form_type":"S-3","shelf_size_usd":1397532,"shelf_size_million_usd":1.397532,"is_atm":true,"sales_agents":["H.C. Wainwright"],"use_of_proceeds_excerpt":"40 SELLING STOCKHOLDERS 40 PLAN OF DISTRIBUTION 43 DESCRIPTION OF SECURITIES 45 DIVIDEND POLICY 48 LEGAL MATTERS 48 EXPERTS 48 WHERE YOU CAN FIND MORE INFORMATION 48 INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE 49 PART II INFORMATION NOT REQUIRED "},{"accession_number":"0001628280-26-057140","company_name":"Voyager Technologies, Inc./TX","filed_at":"2026-08-14T16:20:23-04:00","cik":"1788060","form_type":"S-3ASR","shelf_size_usd":null,"shelf_size_million_usd":null,"is_atm":true,"sales_agents":[],"use_of_proceeds_excerpt":"We intend to use the net proceeds from the sale of the securities as set forth in the applicable prospectus supplement. We will not receive any of the proceeds from the sale of Class A common stock being offered by any of the selling securityholders."},{"accession_number":"0001140361-26-033149","company_name":"InflaRx N.V.","filed_at":"2026-08-14T16:15:39-04:00","cik":"1708688","form_type":"424B5","shelf_size_usd":75000000,"shelf_size_million_usd":75.0,"is_atm":true,"sales_agents":["Leerink"],"use_of_proceeds_excerpt":"S-9 DIVIDEND POLICY S-10 DILUTION S-11 MATERIAL DUTCH TAX CONSIDERATIONS S-12 MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS S-18 PLAN OF DISTRIBUTION S-23 LEGAL MATTERS S-25 EXPERTS S-26 WHERE YOU CAN FIND MORE INFORMATION S-27 INCORPORATION OF CER"},{"accession_number":"0001628280-26-057108","company_name":"Zentalis Pharmaceuticals, Inc.","filed_at":"2026-08-14T16:09:01-04:00","cik":"1725160","form_type":"424B5","shelf_size_usd":250000000,"shelf_size_million_usd":250.0,"is_atm":true,"sales_agents":["H.C. Wainwright","Cowen","Guggenheim"],"use_of_proceeds_excerpt":"S-11 DIVIDEND POLICY S-12 DILUTION S-13 MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO NON-U.S. HOLDERS S-15 UNDERWRITING S-19 LEGAL MATTERS S-27 EXPERTS S-27 WHERE YOU CAN FIND MORE INFORMATION S-27 INCORPORATION BY REFERENCE S-28 Prospectus ABOUT"},{"accession_number":"0001193125-26-352226","company_name":"CARLSMED, INC.","filed_at":"2026-08-14T16:08:42-04:00","cik":"1794546","form_type":"S-3","shelf_size_usd":250000000,"shelf_size_million_usd":250.0,"is_atm":true,"sales_agents":[],"use_of_proceeds_excerpt":"7 DESCRIPTION OF CAPITAL STOCK 8 DESCRIPTION OF DEBT SECURITIES 14 DESCRIPTION OF WARRANTS 21 DESCRIPTION OF UNITS 23 GLOBAL SECURITIES 24 EXPERTS 30 ABOUT THIS PROSPECTUS This prospectus is part of a registration statement that we filed with the SEC"},{"accession_number":"0001193125-26-352154","company_name":"ACHIEVE LIFE SCIENCES, INC.","filed_at":"2026-08-14T16:04:27-04:00","cik":"949858","form_type":"424B5","shelf_size_usd":300000000,"shelf_size_million_usd":300.0,"is_atm":true,"sales_agents":["Jefferies"],"use_of_proceeds_excerpt":"S-8 DIVIDEND POLICY S-9 DILUTION S-10 PLAN OF DISTRIBUTION S-12 LEGAL MATTERS S-14 EXPERTS S-15 WHERE YOU CAN FIND MORE INFORMATION S-16 INCORPORATION OF INFORMATION BY REFERENCE S-17 Base Prospectus PAGE ABOUT THIS PROSPECTUS 1 PROSPECTUS SUMMARY 2 "},{"accession_number":"0001104659-26-097043","company_name":"Vuzix Corp","filed_at":"2026-08-14T16:00:46-04:00","cik":"1463972","form_type":"424B5","shelf_size_usd":300000000,"shelf_size_million_usd":300.0,"is_atm":true,"sales_agents":["Jefferies"],"use_of_proceeds_excerpt":"S-7 Dilution S-8 Plan of Distribution S-9 Legal Matters S-10 Experts S-10 Where You Can Find More Information S-10 Incorporation of Certain Information by Reference S-11 S-i ABOUT THIS PROSPECTUS SUPPLEMENT This prospectus supplement and the accompan"},{"accession_number":"0001493152-26-038282","company_name":"SKK Holdings Ltd","filed_at":"2026-08-14T15:58:19-04:00","cik":"1991261","form_type":"424B5","shelf_size_usd":null,"shelf_size_million_usd":null,"is_atm":true,"sales_agents":[],"use_of_proceeds_excerpt":"S-7 DIVIDEND POLICY S-7 DILUTION S-7 DESCRIPTION OF SECURITIES S-9 PLAN OF DISTRIBUTION S-9 LEGAL MATTERS S-10 EXPERTS S-10 WHERE YOU CAN FIND ADDITIONAL INFORMATION S-10 INFORMATION INCORPORATED BY REFERENCE S-11 S-i Prospectus ABOUT THIS PROSPECTUS"},{"accession_number":"0000950103-26-012378","company_name":"Ultra Clean Holdings, Inc.","filed_at":"2026-08-14T08:45:49-04:00","cik":"1275014","form_type":"424B5","shelf_size_usd":400000000,"shelf_size_million_usd":400.0,"is_atm":true,"sales_agents":[],"use_of_proceeds_excerpt":"S-9 MATERIAL UNITED STATES FEDERAL INCOME AND ESTATE TAX CONSIDERATIONS FOR NON-U.S. HOLDERS OF COMMON STOCK S-10 PLAN OF DISTRIBUTION S-13 LEGAL MATTERS S-15 EXPERTS S-15 Prospectus Page Ultra Clean Holdings, Inc. 1 About This Prospectus 1 Forward-L"},{"accession_number":"0001104659-26-096504","company_name":"Outlook Therapeutics, Inc.","filed_at":"2026-08-14T08:30:37-04:00","cik":"1649989","form_type":"424B5","shelf_size_usd":300000000,"shelf_size_million_usd":300.0,"is_atm":true,"sales_agents":["H.C. Wainwright","BTIG","Piper Sandler"],"use_of_proceeds_excerpt":"​ ​ ​ ​ S-12 ​ ​ DILUTION ​ ​ ​ ​ S-13 ​ ​ Description of Securities We Are Offering ​ ​ ​ ​ S-15 ​ ​ UNDERWRITING ​ ​ ​ ​ S-24 ​ ​ LEGAL MATTERS ​ ​ ​ ​ S-33 ​ ​ EXPERTS ​ ​ ​ ​ S-33 ​ ​ WHERE YOU CAN FIND MORE INFORMATION ​ ​ ​ ​ S-33 ​ ​ INCORPORA"},{"accession_number":"0001108205-26-000116","company_name":"CURIS INC","filed_at":"2026-08-13T17:27:13-04:00","cik":"1108205","form_type":"424B4","shelf_size_usd":null,"shelf_size_million_usd":null,"is_atm":true,"sales_agents":["A.G.P./Alliance Global Partners"],"use_of_proceeds_excerpt":"13 Selected Financial Data 14 Capitalization 15 Dilution 16 Dividend Policy 18 Description of Securities We are Offering 19 Plan of Distribution 25 Material U.S. Federal Income Tax Consequences 28 Legal Matters 35 Experts 36 Where You Can Find More I"},{"accession_number":"0001628280-26-056802","company_name":"CapsoVision, Inc","filed_at":"2026-08-13T16:46:45-04:00","cik":"1378325","form_type":"S-3","shelf_size_usd":250000000,"shelf_size_million_usd":250.0,"is_atm":true,"sales_agents":["Cantor Fitzgerald"],"use_of_proceeds_excerpt":"8 DESCRIPTION OF CAPITAL STOCK 9 DESCRIPTION OF WARRANTS 14 DESCRIPTION OF RIGHTS 16 DESCRIPTION OF UNITS 17 PLAN OF DISTRIBUTION 18 LEGAL MATTERS 20 EXPERTS 20 i ABOUT THIS PROSPECTUS This prospectus is part of a registration statement on Form S-3 t"},{"accession_number":"0001140361-26-032832","company_name":"ONE LIBERTY PROPERTIES INC","filed_at":"2026-08-13T16:31:41-04:00","cik":"712770","form_type":"S-3","shelf_size_usd":250000000,"shelf_size_million_usd":250.0,"is_atm":true,"sales_agents":[],"use_of_proceeds_excerpt":"7 DESCRIPTION OF CAPITAL STOCK 8 DESCRIPTION OF WARRANTS 10 DESCRIPTION OF SUBSCRIPTION RIGHTS 11 PROVISIONS OF MARYLAND LAW AND OF OUR CHARTER AND BYLAWS 12 FEDERAL INCOME TAX CONSIDERATIONS 16 STATE AND LOCAL TAXES 35 IMPORTANCE OF OBTAINING PROFES"},{"accession_number":"0001193125-26-349330","company_name":"Seres Therapeutics, Inc.","filed_at":"2026-08-13T16:31:15-04:00","cik":"1609809","form_type":"S-3","shelf_size_usd":300000000,"shelf_size_million_usd":300.0,"is_atm":true,"sales_agents":["Cowen"],"use_of_proceeds_excerpt":"6 DESCRIPTION OF CAPITAL STOCK 7 DESCRIPTION OF DEBT SECURITIES 10 DESCRIPTION OF WARRANTS 18 DESCRIPTION OF UNITS 20 GLOBAL SECURITIES 21 PLAN OF DISTRIBUTION 25 LEGAL MATTERS 27 EXPERTS 27 ABOUT THIS PROSPECTUS This prospectus is part of a registra"},{"accession_number":"0001193125-26-349250","company_name":"CAMPBELL'S Co","filed_at":"2026-08-13T16:16:51-04:00","cik":"16732","form_type":"S-3ASR","shelf_size_usd":null,"shelf_size_million_usd":null,"is_atm":true,"sales_agents":[],"use_of_proceeds_excerpt":"5 Description of Debt Securities 5 Description of Capital Stock 16 Description of Preferred Stock 19 Description of Other Securities 19 Plan of Distribution 19 Legal Opinions 20 Experts 21 i Table of Contents ABOUT THIS PROSPECTUS This prospectus is "},{"accession_number":"0001628280-26-056729","company_name":"Zentalis Pharmaceuticals, Inc.","filed_at":"2026-08-13T16:14:20-04:00","cik":"1725160","form_type":"424B5","shelf_size_usd":250000000,"shelf_size_million_usd":250.0,"is_atm":true,"sales_agents":["Cowen","Guggenheim"],"use_of_proceeds_excerpt":"S-12 DIVIDEND POLICY S-13 DILUTION S-14 DESCRIPTION OF PRE-FUNDED WARRANTS S-16 MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES S-17 UNDERWRITING S-23 LEGAL MATTERS S-31 EXPERTS S-31 WHERE YOU CAN FIND MORE INFORMATION S-31 INCORPORATION BY REFERENCE S"},{"accession_number":"0001104659-26-095880","company_name":"Haleon US Capital LLC","filed_at":"2026-08-13T16:01:44-04:00","cik":"2149389","form_type":"424B5","shelf_size_usd":null,"shelf_size_million_usd":null,"is_atm":true,"sales_agents":["Citigroup Global Markets","Goldman Sachs"],"use_of_proceeds_excerpt":"​ ​ ​ ​ S-10 ​ ​ Capitalization and Indebtedness ​ ​ ​ ​ S-11 ​ ​ United States Taxation ​ ​ ​ ​ S-13 ​ ​ United Kingdom Taxation ​ ​ ​ ​ S-14 ​ ​ Underwriting (Conflicts of interest) ​ ​ ​ ​ S-15 ​ ​ Where You Can Find More Information About Us ​ ​ "},{"accession_number":"0001178913-26-004116","company_name":"Silexion Therapeutics Corp","filed_at":"2026-08-13T11:01:15-04:00","cik":"2022416","form_type":"424B4","shelf_size_usd":15000000,"shelf_size_million_usd":15.0,"is_atm":true,"sales_agents":["H.C. Wainwright"],"use_of_proceeds_excerpt":"40 Capitalization 41 Market Information for Securities and Dividend Policy 42 Management’s Discussion and Analysis of Financial Condition and Results of Operations 43 Business 60 Management 86 Executive Compensation 92 Certain Relationships and Relat"},{"accession_number":"0001193125-26-348013","company_name":"ADVANCED MICRO DEVICES INC","filed_at":"2026-08-13T08:48:12-04:00","cik":"2488","form_type":"S-3ASR","shelf_size_usd":null,"shelf_size_million_usd":null,"is_atm":true,"sales_agents":[],"use_of_proceeds_excerpt":"6 Description of Debt Securities 7 Global Securities 15 Plan of Distribution 19 Legal Matters 20 Experts 20 Table of Contents ABOUT THIS PROSPECTUS This prospectus is part of a registration statement that we filed with the U.S. Securities and Exchang"},{"accession_number":"0001193125-26-347943","company_name":"Savers Value Village, Inc.","filed_at":"2026-08-13T08:09:52-04:00","cik":"1883313","form_type":"424B5","shelf_size_usd":50000000,"shelf_size_million_usd":50.0,"is_atm":true,"sales_agents":["Jefferies","BTIG","Piper Sandler","Goldman Sachs"],"use_of_proceeds_excerpt":"S-14 DIVIDEND POLICY S-15 SELLING STOCKHOLDERS S-16 MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS S-18 UNDERWRITING S-22 LEGAL MATTERS S-32 EXPERTS S-32 ABOUT THIS PROSPECTUS 1 INCORPORATION BY REFERENCE 3 SPECIAL NOTE REGARDING FORWARD-LOOKING STA"},{"accession_number":"0001213900-26-088706","company_name":"VEEA INC.","filed_at":"2026-08-13T08:00:19-04:00","cik":"1840317","form_type":"424B5","shelf_size_usd":75000000,"shelf_size_million_usd":75.0,"is_atm":true,"sales_agents":["Roth Capital"],"use_of_proceeds_excerpt":"S-9 DIVIDEND POLICY S-10 DILUTION S-11 PLAN OF DISTRIBUTION S-12 LEGAL MATTERS S-14 EXPERTS S-14 WHERE YOU CAN FIND MORE INFORMATION S-14 INCORPORATION BY REFERENCE S-15 Prospectus Page ABOUT THIS PROSPECTUS ii RISK FACTORS 1 CAUTIONARY NOTE REGARDIN"},{"accession_number":"0001193125-26-347828","company_name":"enCore Energy Corp.","filed_at":"2026-08-13T06:51:30-04:00","cik":"1500881","form_type":"424B5","shelf_size_usd":700000000,"shelf_size_million_usd":700.0,"is_atm":true,"sales_agents":["Cantor Fitzgerald","B. Riley Securities"],"use_of_proceeds_excerpt":"S-6 DILUTION S-7 PLAN OF DISTRIBUTION S-8 CANADIAN TAX PROPOSAL S-10 WHERE YOU CAN FIND MORE INFORMATION S-11 DOCUMENTS INCORPORATED BY REFERENCE S-11 LEGAL MATTERS S-13 EXPERTS S-13 Prospectus ABOUT THIS PROSPECTUS 1 CAUTIONARY NOTE REGARDING FORWAR"}],"note":"Showing past 72h. Free 3-day Pro trial (no card): https://filingfirehose.com/trial"}